{
    "@xmlns:dc": "http://purl.org/dc/elements/1.1/",
    "dc:title": "THE EFFECTS OF CHLORPROPAMIDE AND INSULIN ON SERUM LIPIDS, LIPOPROTEINS AND FRACTIONAL TRIGLYCERIDE REMOVAL",
    "dc:creator": [
        "PAISEY R",
        "ELKELES RS",
        "HAMBLEY J",
        "MAGILL P"
    ],
    "dc:date": "1978",
    "dc:type": "Article",
    "dc:language": "English",
    "dc:format": "DIABETOLOGIA; DEU; DA. 1978; VOL. 15; NO 2; PP. 81-85; BIBL. 21 REF.",
    "dc:subject": [
        {
            "@xml:lang": "fr",
            "#text": "DIABETE"
        },
        {
            "@xml:lang": "fr",
            "#text": "CHIMIOTHERAPIE"
        },
        {
            "@xml:lang": "fr",
            "#text": "INSULINE"
        },
        {
            "@xml:lang": "fr",
            "#text": "LIPIDE"
        },
        {
            "@xml:lang": "fr",
            "#text": "LIPOPROTEINE"
        },
        {
            "@xml:lang": "fr",
            "#text": "TRIGLYCERIDE"
        },
        {
            "@xml:lang": "fr",
            "#text": "HYPOGLYCEMIANT"
        },
        {
            "@xml:lang": "fr",
            "#text": "TAUX"
        },
        {
            "@xml:lang": "fr",
            "#text": "SANG"
        },
        {
            "@xml:lang": "fr",
            "#text": "ETUDE COMPARATIVE"
        },
        {
            "@xml:lang": "fr",
            "#text": "HOMME"
        },
        {
            "@xml:lang": "fr",
            "#text": "METABOLISME"
        },
        {
            "@xml:lang": "fr",
            "#text": "TRAITEMENT"
        },
        {
            "@xml:lang": "fr",
            "#text": "HORMONE PEPTIDE"
        },
        {
            "@xml:lang": "fr",
            "#text": "ENDOCRINOPATHIE"
        },
        {
            "@xml:lang": "fr",
            "#text": "CHLORPROPAMIDE"
        },
        {
            "@xml:lang": "fr",
            "#text": "ENDOCRINOLOGIE"
        },
        {
            "@xml:lang": "en",
            "#text": "DIABETES MELLITUS"
        },
        {
            "@xml:lang": "en",
            "#text": "CHEMOTHERAPY"
        },
        {
            "@xml:lang": "en",
            "#text": "INSULIN"
        },
        {
            "@xml:lang": "en",
            "#text": "LIPIDS"
        },
        {
            "@xml:lang": "en",
            "#text": "LIPOPROTEIN"
        },
        {
            "@xml:lang": "en",
            "#text": "TRIGLYCERIDE"
        },
        {
            "@xml:lang": "en",
            "#text": "HYPOGLYCEMIC AGENT"
        },
        {
            "@xml:lang": "en",
            "#text": "BLOOD"
        },
        {
            "@xml:lang": "en",
            "#text": "COMPARATIVE STUDY"
        },
        {
            "@xml:lang": "en",
            "#text": "HUMAN"
        },
        {
            "@xml:lang": "en",
            "#text": "METABOLISM"
        },
        {
            "@xml:lang": "en",
            "#text": "TREATMENT"
        },
        {
            "@xml:lang": "en",
            "#text": "PEPTIDE HORMONE"
        },
        {
            "@xml:lang": "en",
            "#text": "ENDOCRINOPATHY"
        },
        {
            "@xml:lang": "en",
            "#text": "ENDOCRINOLOGY"
        },
        "002B21: Endocrinopathies / Endocrinopathies"
    ],
    "dc:rights": [
        "Inist-CNRS",
        "Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS"
    ],
    "dc:identifier": "Inist-CNRS record number PASCAL7950092573"
}